Notizia - Recent Pharma, Healthcare and Biotech Happenings

AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan.   AbbVie this year in June has agreed to buy Allergan for USD 63 Billion, which is one of the largest deals this year. The acquisition will help AbbVie to diversify its drug portfolio which mostly revolves around Humira. Humira (adalimumab) is a tumour necrosis factor (TNF) blocker that helps to reduce the effects of inflammation due to any substance. Used to treat inflammatory disorders in adults such as ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. ...